Shikonin as an inhibitor of the LPS-induced epithelial-to-mesenchymal transition in human breast cancer cells

International Journal of Molecular Medicine

Volumn 36, Issue 6, 2015, Pages 1601-1606

  Hong, Darong ^a   Jang, Soon Young ^a   Jang, Eun Hyang ^a   Jung, Bom ^a   Cho, In Hye ^a   Park, Min Ju ^a   Jeong, Seo Young ^a   Kim, Jong Ho ^a  

^a Kyung Hee University Hospital   (South Korea)

Author keywords

Epithelial to mesenchymal transition; Invasion; Migration; NF B Snail signaling pathway; Shikonin

Indexed keywords

ANTINEOPLASTIC AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; NERVE CELL ADHESION MOLECULE; SHIKONIN; TRANSCRIPTION FACTOR SNAIL; UVOMORULIN; CADHERIN; HERBACEOUS AGENT; NAPHTHOQUINONE; NONSTEROID ANTIINFLAMMATORY AGENT; SNAIL FAMILY TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RELA;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; EPITHELIAL MESENCHYMAL TRANSITION; GENE INACTIVATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MCF 7 CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE; BREAST TUMOR; CELL MOTION; CELL PROLIFERATION; CELL SURVIVAL; DOSE RESPONSE; DRUG EFFECTS; FEMALE; FLUORESCENCE MICROSCOPY; METABOLISM; PATHOLOGY; TUMOR CELL LINE; WESTERN BLOTTING;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BLOTTING, WESTERN; BREAST NEOPLASMS; CADHERINS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; LIPOPOLYSACCHARIDES; MCF-7 CELLS; MICROSCOPY, FLUORESCENCE; NAPHTHOQUINONES; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTORS;

EID: 84945433727     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2015.2373     Document Type: Article

References (32)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, and Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 59: 225-249, 2009
2. Parkin DM, Bray F, Ferlay J, and Pisani P. Global cancer statis-tics, 2002. CA Cancer J Clin 55: 74-108, 2005
3. Coleman RE, Gregory W, Marshall H, Wilson C, and Holen I. The metastatic microenvironment of breast cancer: Clinical implications. Breast 22 (Suppl 2): S50-S56, 2013
4. Sleeman JP, Nazarenko I, and Thiele W. Do all roads lead to Rome?. Routes to metastasis development. Int J Cancer 128: 2511 2526, 2011
5. Steeg PS. Tumor metastasis: Mechanistic insights, and clinical challenges. Nat Med 12: 895-904, 2006
6. Gupta GP, Minn AJ, Kang Y, Siegel PM, Serganova I, Cordón-Cardo C, Olshen AB, Gerald WL, and Massagué J. Identifying site-specific metastasis genes, and functions. Cold Spring Harb Symp Quant Biol 70: 149-158, 2005
7. Klein CA. Parallel progression of primary tumours, and metas-tases. Nat Rev Cancer 9: 302-312, 2009
8. Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, Giri DD, Viale A, Olshen AB, Gerald WL, and Massagué J. Genes that mediate breast cancer metastasis to lung. Nature 436: 518-524, 2005
9. Kong D, Li Y, Wang Z, and Sarkar FH. Cancer stem cells, and epithelial-to-mesenchymal transition (EMT)-phenotypic cells: Are they cousins or twins?. Cancers (Basel) 3: 716-729, 2011
10. Polyak K, and Weinberg RA. Transitions between epithelial, and mesenchymal states: Acquisition of malignant, and stem cell traits. Nat Rev Cancer 9: 265-273, 2009
11. Thiery JP, Acloque H, Huang RY, and Nieto MA. Epithelial-mesenchymal transitions in development, and disease. Cell 139: 871-890, 2009
12. Yang H, Zhou P, Huang H, Chen D, Ma N, Cui QC, Shen S, Dong W, Zhang X, Lian W, et al. Shikonin exerts antitumor activity via proteasome inhibition, and cell death induction in vitro, and in vivo. Int J Cancer 124: 2450-2459, 2009
13. Chen Y, Zheng L, Liu J, Zhou Z, Cao X, Lv X, and Chen F. Shikonin inhibits prostate cancer cells metastasis by reducing matrix metalloproteinase-2/-9 expression via AKT/mTOR, and ROS/ERK1/2 pathways. Int Immunopharmacol 21: 447-455, 2014
14. Yeh CC, Kuo HM, Li TM, Lin JP, Yu FS, Lu HF, Chung JG, and Yang JS. Shikonin-induced apoptosis involves caspase-3 activity in a human bladder cancer cell line (T24). In Vivo 21: 1011-1019, 2007
15. Zhang FL, Wang P, Liu YH, Liu LB, Liu XB, Li Z, and Xue YX. Topoisomerase I inhibitors, shikonin, and topotecan, inhibit growth, and induce apoptosis of glioma cells, and glioma stem cells. PLoS One 8: e81815, 2013
16. Fujii N, Yamashita Y, Arima Y, Nagashima M, and Nakano H. Induction of topoisomerase II-mediated DNA cleavage by the plant naphthoquinones plumbagin, and shikonin. Antimicrob Agents Chemother 36: 2589-2594, 1992
17. Jang SY, Lee JK, Jang EH, Jeong SY, and Kim JH. Shikonin blocks migration, and invasion of human breast cancer cells through inhibition of matrix metalloproteinase-9 activation. Oncol Rep 31: 2827-2833, 2014
18. Wu K, and Bonavida B. The activated NF-kappaB-Snail-RKIP circuitry in cancer regulates both the metastatic cascade, and resistance to apoptosis by cytotoxic drugs. Crit Rev Immunol 29: 241-254, 2009
19. Friedl P, and Wolf K. Tumour-cell invasion, and migration: Diversity, and escape mechanisms. Nat Rev Cancer 3: 362-374, 2003
20. De Craene B, and Berx G. Regulatory networks defining EMT during cancer initiation, and progression. Nat Rev Cancer 13: 97-110, 2013
21. Kalluri R, and Weinberg RA. The basics of epithelial-mesen-chymal transition. J Clin Invest 119: 1420-1428, 2009
22. Mulholland DJ, Kobayashi N, Ruscetti M, Zhi A, Tran LM, Huang J, Gleave M, and Wu H. Pten loss, and RAS/MAPK activa-tion cooperate to promote EMT, and metastasis initiated from prostate cancer stem/progenitor cells. Cancer Res 72: 1878-1889, 2012
23. Wu Y, Deng J, Rychahou PG, Qiu S, Evers BM, and Zhou BP. Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration, and invasion. Cancer Cell 15: 416-428, 2009
24. Zhang HJ, Wang HY, Zhang HT, Su JM, Zhu J, Wang HB, Zhou WY, Zhang H, Zhao MC, Zhang L, et al. Transforming growth factor-β1 promotes lung adenocarcinoma invasion, and metastasis by epithelial-to-mesenchymal transition. Mol Cell Biochem 355: 309-314, 2011
25. Gara RK, Srivastava VK, Duggal S, Bagga JK, Bhatt M, Sanyal S, and Mishra DP. Shikonin selectively induces apoptosis in human prostate cancer cells through the endoplasmic reticulum stress, and mitochondrial apoptotic pathway. J Biomed Sci 22: 26, 2015
26. van Roy F, and Berx G. The cell-cell adhesion molecule E-cadherin. Cell Mol Life Sci 65: 3756-3788, 2008
27. Lombaerts M, van Wezel T, Philippo K, Dierssen JW, Zimmerman RM, Oosting J, van Eijk R, Eilers PH, van de Water B, Cornelisse CJ, et al. E-cadherin transcriptional down-regulation by promoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell lines. Br J Cancer 94: 661-671, 2006
28. Nguyen PT, Kudo Y, Yoshida M, Kamata N, Ogawa I, and Takata T. N-cadherin expression is involved in malignant behavior of head, and neck cancer in relation to epithelial-mesenchymal transition. Histol Histopathol 26: 147-156, 2011
29. Araki K, Shimura T, Suzuki H, Tsutsumi S, Wada W, Yajima T, Kobayahi T, Kubo N, and Kuwano H. E/N-cadherin switch mediates cancer progression via TGF-β-induced epithelial-to-mesenchymal transition in extrahepatic cholangiocarcinoma. Br J Cancer 105: 1885-1893, 2011
30. Ennen M, Klotz R, Touche N, Pinel S, Barbieux C, Besancenot V, Brunner E, Thiebaut D, Jung AC, Ledrappier S, et al. DDB2: A novel regulator of NF-κB, and breast tumor invasion. Cancer Res 73: 5040-5052, 2013
31. Chua HL, Bhat-Nakshatri P, Clare SE, Morimiya A, Badve S, and Nakshatri H. NF-kappaB represses E-cadherin expression, and enhances epithelial to mesenchymal transition of mammary epithelial cells: Potential involvement of ZEB-1, and ZEB-2. Oncogene 26: 711-724, 2007
32. Min C, Eddy SF, Sherr DH, and Sonenshein GE. NF-kappaB, and epithelial to mesenchymal transition of cancer. J Cell Biochem 104: 733-744, 2008